mortality/aging
• median survival is 122 days instead of 182 days for Trp53tm1Tyj homozygotes
|
neoplasm
• mice exhibit a 2.4-fold increase in thymic lymphomas compared with Trp53tm1Tyj homozygotes
• thymic lymphomas are more aggressive than in Trp53tm1Tyj homozygotes
|
immune system
• at 3 and 6 months
|
hematopoietic system
• at 3 and 6 months
|
endocrine/exocrine glands
• at 3 and 6 months
|
• mice exhibit a 2.4-fold increase in thymic lymphomas compared with Trp53tm1Tyj homozygotes
• thymic lymphomas are more aggressive than in Trp53tm1Tyj homozygotes
|